KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announces that nonclinical data on PV-10 will be presented at the Society for Immunotherapy of Cancer Annual Meeting on October 26 and 27, 2012 in North Bethesda, MD.
